Top Markets
#1 Derive Derive +32.37%
#2 Cross Cross +15.42%
#3 Glidr Glidr +10.10%
#4 Gama Token Gama Token +9.10%
#5 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +6.92%
#6 Palladium Network Palladium Network +6.09%
#7 Based Based +5.99%
#8 Geodnet Geodnet +5.11%
#9 龙虾 (Lobster) 龙虾 (Lobster) +5.09%
#10 Talus Network Talus Network +4.83%
Coin of the day
Derive Derive
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Delota Corp. Delota Corp.

Delota Corp.

SYDRF
Clasificación en acciones #36225
Delota Corp. operates as a Canadian retail company, primarily focusing on the... Delota Corp. operates as a Canadian retail company, primarily focusing on the sale of diverse cannabis products. Their product range also encompasses various vaping and nicotine-related items, herbal vaporizers, and other smoking cessation solutions, along with their complementary accessories. The firm manages a network of 26 brick-and-mortar retail establishments complemented by an online e-commerce platform. These operations are conducted under its two prominent brands: 180 Smoke and Offside Cannabis. The company, which is headquartered in Concord, Canada, transitioned its name to Delota Corp. in November 2021, having previously been recognized as Spyder Cannabis Inc.
Precio por acción
$0.1
Última sincronización: 2026-08-13
Capitalización bursátil
$2.91M
Cambio (1 día)
0.00%
Cambio (1 año)
25.00%
País
CA
Comercio Delota Corp. (SYDRF)

Categoría

Healthcare
Ingresos de Delota Corp. (SYDRF)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Delota Corp., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Delota Corp. desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US